J Alejandro Pérez-Fidalgo

Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Place...

Immunotherapy and PARP inhibitors as eerstelijns treatment in endometrial cancer: A systematic review and network met...

Atezolizumab plus platina plus niraparib-onderhoud bij recidief ovariumcarcinoom met platina-vrij interval

Atezolizumab plus bevacizumab plus chemo bij gemetastaseerd/recidief cervixcarcinoom: BEATcc fase III